Profound Medical(PROF)
Focus: Profound Medical is a Canadian medical technology company specializing in real-time MRI-guided surgical ablation systems for oncology, primarily prostate cancer treatment. The company is public (TSX: PROF) and operates as a precision medical device innovator with an expanding commercial footprint.
Profile data last refreshed 51m ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
25+3 this month
Stable — net +3 jobs in 30d
16 added, 13 removed. Backfill posture.
Should You Work at Profound Medical?
AI assessmentBest fit for medtech-focused professionals and commercial operators comfortable with early-stage risk; traditional pharma candidates should verify alignment with device-based oncology focus.
Why Work Here
- Heavy R&D investment (159% intensity) signals commitment to technology advancement and innovation—ideal for engineers and clinical scientists wanting deep technical work.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$11M
Pipeline & Clinical Trials
Radical Prostatectomy
Prostate CancerClinical Trials (1)
NCT05027477A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer
N/AHelp build intelligence for Profound Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.